Oramed Pharmaceuticals Valuation
| ORMP Stock | 8.60 0.02 0.23% |
At this time, the company appears to be overvalued. Oramed Pharmaceuticals holds a recent Real Value of 8.08 per share. The prevailing price of the company is 8.6. Our model determines the value of Oramed Pharmaceuticals from analyzing the company fundamentals such as Current Valuation of 156.33 M, return on equity of -78.51, and Price To Book of 866.13 X as well as examining its technical indicators and probability of bankruptcy. In general, most investors support taking in undervalued entities and trading overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Oramed Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Oramed Pharmaceuticals is based on 3 months time horizon. Increasing Oramed Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Oramed Pharmaceuticals is useful when determining the fair value of the Oramed stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Oramed Pharmaceuticals. Since Oramed Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oramed Stock. However, Oramed Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.6 | Real 8.08 | Hype 8.6 |
The real value of Oramed Stock, also known as its intrinsic value, is the underlying worth of Oramed Pharmaceuticals Company, which is reflected in its stock price. It is based on Oramed Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Oramed Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Oramed Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Oramed Pharmaceuticals helps investors to forecast how Oramed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oramed Pharmaceuticals more accurately as focusing exclusively on Oramed Pharmaceuticals' fundamentals will not take into account other important factors: Oramed Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Oramed Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Oramed Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oramed Pharmaceuticals competition to find correlations between indicators driving Oramed Pharmaceuticals's intrinsic value. More Info.Oramed Pharmaceuticals is considered to be number one stock in price to book category among related companies. It is considered to be number one stock in beta category among related companies . The ratio of Price To Book to Beta for Oramed Pharmaceuticals is about 704.17 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Oramed Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Oramed Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oramed Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Oramed Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Oramed Pharmaceuticals and how it compares across the competition.
About Oramed Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Oramed Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Oramed Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Oramed Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Oramed Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Oramed Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oramed Pharmaceuticals. We calculate exposure to Oramed Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oramed Pharmaceuticals's related companies.Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. ORAMED PHARMA is traded on Tel Aviv Stock Exchange in Israel.
8 Steps to conduct Oramed Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Oramed Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Oramed Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Oramed Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Oramed Pharmaceuticals' revenue streams: Identify Oramed Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Oramed Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Oramed Pharmaceuticals' growth potential: Evaluate Oramed Pharmaceuticals' management, business model, and growth potential.
- Determine Oramed Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Oramed Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oramed Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |